Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Prognostic implications of HER2NEU‐low in metastatic breast cancer
Prognostic implications of HER2NEU‐low in metastatic breast cancer
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Zachary Neubauer
,
Shaakir Hasan
,
Robert H. Press
,
Arpit M. Chhabra
,
Jana Fox
,
Richard Bakst
,
Charles B. Simone
,
J. Isabelle Choi
Format:
Artículo Open Access
Published:
Wiley
2024
Subjects:
Cancer Medicine
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Description
DOI:
10.1002/cam4.6979
Similar Items
The efficiency and safety of low‐dose apatinib combined with oral vinorelbine in pretreated HER2‐negative metastatic breast cancer
by: Jia‐Yi Huang, et al.
Published: (2024)
Trastuzumab deruxtecan in previously treated HER2‐positive metastatic or unresectable breast cancer: Real‐life data from the temporary use authorization program in France
by: Thierry Petit, et al.
Published: (2024)
Efficacy and safety of eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with anthracycline/taxanes
by: Lan Chen, et al.
Published: (2024)
Pathological and clinical outcomes following neoadjuvant dual HER2 therapy for early‐stage breast cancer: An Australian institutional real‐world experience
by: Sathya Narayanan, et al.
Published: (2024)
Nomograms for predicting recurrence of HER2‐positive breast cancer with different HR status based on ultrasound and clinicopathological characteristics
by: Xudong Zhang, et al.
Published: (2024)